Lantern Pharma Inc. is a biotechnology company focused on developing personalized therapeutic approaches for cancer patients. The company utilizes advanced bioinformatics and artificial intelligence to identify genetic and molecular characteristics of cancer tumors, enabling better targeting of therapeutic strategies for individual patients. Lantern Pharma focuses on discovering and developing new drugs and combination therapies that could be effective in patients with various types of cancer, including those who have not been successfully treated by standard methods. The goal of Lantern Pharma is to bring innovative treatment approaches and improve treatment outcomes for cancer patients.